Rat 13762 mammary adenocarcinoma cell clones of differing spontaneous metastatic potentials were tested for their sensitivities to Adriamycin, 5-fluoro-2-′-deoxyuridine (FUdR) and methotrexate in vitro. Cells were treated 4 hours with a single dose of drug, and colony formation was used to assay cell survival. Dose-response curves and survival parameters were calculated for local tumor-derived clones MTC and MTF7 and lung metastasis-derived clone MTLn3. The logarithmic curves were analyzed (slope and y-intercepts) for statistical comparisons. Heterogeneous sensitivities to Adriamycin and FUdR were observed, but there was no difference in the sensitivities of the clones to methotrexate cell killing. We could not find correlations between drug response and clonal origin, passage number or metastatic properties. The sensitivities of the clones to Adriamycin and FUdR changed upon in vitro passage, although drift in Adriamycin sensitivity during growth in culture was not statistically significant. The results demonstrate that (i) clonal heterogeneity exists within the 13762 tumor and its metastases in their inherent responses to chemotherapy agents, and (ii) in the absence of host selective pressures tumor cells can spontaneously and reproducibly drift in their sensitivities to certain chemotherapeutic drugs.
Similar content being viewed by others
References
Barranco, S. C., Haenell, B. R., and Gee, E. L., 1978, Differential sensitivities of five rat hepatomas cell lines to anticancer drugs. Cancer Research, 38, 656–660.
Byers, V. S., and Johnston, J. O., 1977, Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors. Cancer Research, 37, 3173–3183.
Chambers, A. F., Hill, R. P., and Ling, V., 1982, Tumor heterogeneity and stability of the metatatic phenotype of mouse KHT sarcoma cells. Cancer Research, 41, 1368–1372.
Dewyngaert, J. K., Leith, J. T., Peck, R. A., Bliven, A. F., Zeman, E. M., Marino, S. A., and Glicksman, A. S., 1981, Differential RBE values obtained for mammary adenocarcinoma tumor cell subpopulations after 14–8-neutron irradiation. Radiation Research, 88, 118–131.
Dexter, D. L., Kowalski, H. M., Blazar, B. A., Fligiel, Z., Vogel, R., and Heppner, G. H., 1978, Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Research, 38, 3174–3181.
Fidler, I. J., and Hart, I. R., 1982, Biological diversity in metastatic neoplasms: Origins and Implications. Science, N. Y., 217, 998–1003.
Fidler, J., and Kripke, M., 1977, Metastasis results from preexisting variant cells within a malignant tumor. Science, N. Y., 197, 893–895.
Fogel, M., Gorelik, E., Segal, S., and Feldman, M., 1979, Differences in cell surface antigens of tumor metastases and those of the local tumor. Journal of the National Cancer Institute, 62, 585–588.
Foulds, T., 1956, The histologic analysis of mammary tumors of mice. Journal of the National Cancer Institute, 17, 701–801.
Grdina, D. J., Basic, I., Mason, K. A., and Withers, H. R., 1975, Radiation response of clonogenic cell populations separated from a fibrosarcoma. Radiation Research, 63, 483–493.
Hart, I. R., and Fidler, I. J., 1981, The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochimica et Biophysica Acta, 651, 37–50.
Heppner, G. H., Dexter, D. L., Denucci, T., Miller, F. R., and Calabressi, P., 1978, Heterogeneity in drug sensitivity among tumor cell subpopulation of a single mammary tumor. Cancer Research, 38, 3758–3763.
Hill, H. Z., Hill, G. J., Miller, C. F., Kwong, T., and Purdy, J., 1979, Radiation and melanoma: response of B16 mouse tumor cells and clonal lines to in vitro irradiation. Radiation Research, 80, 259–276.
Lotan, R., and Nicolson, G. L., 1979, Heterogeneity in growth inhibition of β-trans- retinoic acid of metastatic B16 melanoma clones and in vivo-selected variant lines. Cancer Research, 39, 4767–4771.
NERI, A., and Nicolson, G. L., 1981, Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro. International Journal of Cancer, 28, 731–738.
Neri, A., Rouslahti, E., and Nicolson, G. L., 1981, Distribution of fibronectin on clonal cell lines of a rat mammary adenocarcinoma growing in vitro and in vivo at primary and metastatic sites. Cancer Research, 41, 5082–5092.
Neri, A., Welch, D. R., Kawaguchi, T., and Nicolson, G. L., 1982, The development and biologic properties'of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. Journal of the National Cancer Institute, 68, 507–517.
Nicolson, G. L., 1978, Experimental tumor metastasis: Characteristics and Organ Specificity. BioScience, 28, 441–447.
Nicolson, G. L., 1982, Cancer Metastasis: Organ colonization and the cell surface properties of malignant cells. Biochimica et Biophysica Acta, 695, 113–176.
Nicolson, G. L., Lotan, R., and Rios, A., 1981, Heterogeneous in vitro sensitivities of metastatic B16 melanoma sublines and clones to retinoic acid or BCNU. Cancer Treatment Reports, 65, (suppl. 2) 71–74.
Nicolson, G. L., and Posts, G., 1982, Tumor cell diversity and host responses in cancer metastasis. I. Properties of metastatic cells. Current Problems in Cancer, 7, 1–83.
Nicolson, G. L., and Posts, G., 1983, Tumor cell diversity and host responses in cancer metastasis. II. Host immune responses and therapy of metastases. Current Problems in Cancer, 7, 1–43.
Pimm, M. V., and Baldwin, R. W., 1977, Antigenic differences between primary methyl cholanthrene-induced rat sarcoma and post surgical recurrences. International Journal of Cancer, 20, 37–43.
Posts, G., Doll, J., and Fidler, I. J., 1981, Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proceedings of the National Academy of Sciences, 78, 6226–6230.
Raz, A., McLellan, W. L., Hart, I. R., Bucana, C. D., Hoyer, L. C., Sela, B.-A., Dragsten, P., and Fidler, I. J., 1980, Cell surface properties of B16 melanoma variants with differing metastatic potential. Cancer Research, 40, 1645–1651.
Reading, C. L., Brunson, K. W., Torriani, M., and Nicolson, G. L., 1980, Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. Proceedings of the National Academy of Sciences, 77, 5983–5947.
Revesz, L., and Norman, L., 1963, Relationship between chromosome ploidy and radiosensitivity in selected tumor sublines of common origin. Journal of the National Cancer Institute, 25, 1041–1063.
Schlag, P., and Schremi, W., 1982, Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay. Cancer Research, 42, 4086–4089.
Tomasovic, S. P., Thames, H. D., and Nicolson, G. L., 1982, Heterogeneity in hyperthermic sensitivities of rat 13762NF mammary adenocarcinoma cell clones of differing metastatic potential. Radiation Research, 91, 555–563.
Tsuruo, T., and Fidler, I. J., 1981, Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Cancer Research, 41, 3058–3064.
Welch, D. R., Milas, L., Tomasovic, S. P., and Nicolson, G. L., 1983, Heterogeneous response and clonal drift of sensitivities of metastatic 13762NF mammary adenocarcinoma clones to gamma radiation in vitro. Cancer Research, 43, 6–10.
Welch, D. R., Neri, A., and Nicolson, G. L., 1983, Comparison of ‘spontaneous’ and experimental metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion and Metastasis, 3, 65–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Welch, D.R., Nicolson, G.L. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to Adriamycin, 5-fluoro-2′-deoxyuridine and methotrexate treatment in vitro . Clin Exp Metast 1, 317–325 (1983). https://doi.org/10.1007/BF00121194
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00121194